2,888
Views
33
CrossRef citations to date
0
Altmetric
RESEARCH PAPER

Combined analysis of DNA methylation and cell cycle in cancer cells

, , , , , , & show all
Pages 82-91 | Received 23 Jul 2014, Accepted 02 Dec 2014, Published online: 23 Jan 2015

References

  • Bestor T, Laudano A, Mattaliano R, Ingram V. Cloning and sequencing of a cDNA encoding DNA methyltransferase of mouse cells. the carboxyl-terminal domain of the mammalian enzymes is related to bacterial restriction methyltransferases. J Mol Biol 1988; 203:971-83; PMID:3210246; http://dx.doi.org/10.1016/0022-2836(88)90122-2
  • Okano M, Xie S, Li E. Cloning and characterization of a family of novel mammalian DNA (cytosine-5) methyltransferases. Nat Genet 1998; 19:219-20; PMID:9662389; http://dx.doi.org/10.1038/890
  • Takai D, Jones PA. Comprehensive analysis of CpG islands in human chromosomes 21 and 22. Pro Nat Acad Sci U S A 2002; 99:3740-5; PMID:11891299; http://dx.doi.org/10.1073/pnas.052410099
  • Gardiner-Garden M, Frommer M. CpG islands in vertebrate genomes. J Mol Biol 1987; 196:261-82; PMID:3656447; http://dx.doi.org/10.1016/0022-2836(87)90689-9
  • Illingworth RS, Bird AP. CpG islands–'a rough guide'. FEBS Lett 2009; 583:1713-20; PMID:19376112; http://dx.doi.org/10.1016/j.febslet.2009.04.012
  • Weber M, Hellmann I, Stadler MB, Ramos L, Paabo S, Rebhan M, Schubeler D. Distribution, silencing potential and evolutionary impact of promoter DNA methylation in the human genome. Nat Genet 2007; 39:457-66; PMID:17334365; http://dx.doi.org/10.1038/ng1990
  • Auclair G, Weber M. Mechanisms of DNA methylation and demethylation in mammals. Biochimie 2012; 94:2202-11; PMID:22634371; http://dx.doi.org/10.1016/j.biochi.2012.05.016
  • Deaton AM, Bird A. CpG islands and the regulation of transcription. Gen Dev 2011; 25:1010-22; PMID:21576262; http://dx.doi.org/10.1101/gad.2037511
  • Illingworth RS, Gruenewald-Schneider U, Webb S, Kerr AR, James KD, Turner DJ, Smith C, Harrison DJ, Andrews R, Bird AP. Orphan CpG islands identify numerous conserved promoters in the mammalian genome. PLoS Genet 2010; 6:e1001134; PMID:20885785; http://dx.doi.org/10.1371/journal.pgen.1001134
  • Maunakea AK, Nagarajan RP, Bilenky M, Ballinger TJ, D'Souza C, Fouse SD, Johnson BE, Hong C, Nielsen C, Zhao Y, et al. Conserved role of intragenic DNA methylation in regulating alternative promoters. Nature 2010; 466:253-7; PMID:20613842; http://dx.doi.org/10.1038/nature09165
  • Feinberg AP. Phenotypic plasticity and the epigenetics of human disease. Nature 2007; 447:433-40; PMID:17522677; http://dx.doi.org/10.1038/nature05919
  • Portela A, Esteller M. Epigenetic modifications and human disease. Nat Biotechnol 2010; 28:1057-68; PMID:20944598; http://dx.doi.org/10.1038/nbt.1685
  • Guil S, Esteller M. DNA methylomes, histone codes and miRNAs: tying it all together. Int J Biochem Cell Biol 2009; 41:87-95; PMID:18834952; http://dx.doi.org/10.1016/j.biocel.2008.09.005
  • Jones PA, Baylin SB. The epigenomics of cancer. Cell 2007; 128:683-92; PMID:17320506; http://dx.doi.org/10.1016/j.cell.2007.01.029
  • Esteller M. Cancer epigenomics: DNA methylomes and histone-modification maps. Nat Rev Genet 2007; 8:286-98; PMID:17339880; http://dx.doi.org/10.1038/nrg2005
  • Weber M, Davies JJ, Wittig D, Oakeley EJ, Haase M, Lam WL, Schubeler D. Chromosome-wide and promoter-specific analyses identify sites of differential DNA methylation in normal and transformed human cells. Nat Genet 2005; 37:853-62; PMID:16007088; http://dx.doi.org/10.1038/ng1598
  • Irizarry RA, Ladd-Acosta C, Wen B, Wu Z, Montano C, Onyango P, Cui H, Gabo K, Rongione M, Webster M, et al. The human colon cancer methylome shows similar hypo- and hypermethylation at conserved tissue-specific CpG island shores. Nat Genet 2009; 41:178-86; PMID:19151715; http://dx.doi.org/10.1038/ng.298
  • Yang X, Lay F, Han H, Jones PA. Targeting DNA methylation for epigenetic therapy. Trends Pharmacol Sci 2010; 31:536-46; PMID:20846732; http://dx.doi.org/10.1016/j.tips.2010.08.001
  • Gros C, Fahy J, Halby L, Dufau I, Erdmann A, Gregoire JM, Ausseil F, Vispe S, Arimondo PB. DNA methylation inhibitors in cancer: recent and future approaches. Biochimie 2012; 94:2280-96; PMID:22967704; http://dx.doi.org/10.1016/j.biochi.2012.07.025
  • Li KK, Li F, Li QS, Yang K, Jin B. DNA methylation as a target of epigenetic therapeutics in cancer. Anticancer Agents Med Chem 2013; 13:242-7; PMID:22934696; http://dx.doi.org/10.2174/1871520611313020009
  • Fahy J, Jeltsch A, Arimondo PB. DNA methyltransferase inhibitors in cancer: a chemical and therapeutic patent overview and selected clinical studies. Expert Opin Ther Pat 2012; 22:1427-42; PMID:23033952; http://dx.doi.org/10.1517/13543776.2012.729579
  • Griffiths EA, Gore SD. DNA methyltransferase and histone deacetylase inhibitors in the treatment of myelodysplastic syndromes. Semi Hematol 2008; 45:23-30; PMID:18179966; http://dx.doi.org/10.1053/j.seminhematol.2007.11.007
  • Piekarz RL, Bates SE. Epigenetic modifiers: basic understanding and clinical development. Clin Cancer Res 2009; 15:3918-26; PMID:19509169; http://dx.doi.org/10.1158/1078-0432.CCR-08-2788
  • Hackanson B, Robbel C, Wijermans P, Lubbert M. In vivo effects of decitabine in myelodysplasia and acute myeloid leukemia: review of cytogenetic and molecular studies. Ann Hematol 2005; 84 <s>1:32-8; PMID:16292549; http://dx.doi.org/10.1007/s00277-005-0004-1
  • Navada SC, Steinmann J, Lubbert M, Silverman LR. Clinical development of demethylating agents in hematology. J Clin Invest 2014; 124:40-6; PMID:24382388; http://dx.doi.org/10.1172/JCI69739
  • Issa JP, Kantarjian HM. Targeting DNA methylation. Clin Cancer Res 2009; 15:3938-46; PMID:19509174; http://dx.doi.org/10.1158/1078-0432.CCR-08-2783
  • Jorda M, Peinado MA. Methods for DNA methylation analysis and applications in colon cancer. Mutat Res 2010; 693:84-93; PMID:20599551; http://dx.doi.org/10.1016/j.mrfmmm.2010.06.010
  • Oakeley EJ. DNA methylation analysis: a review of current methodologies. Pharmacol Ther 1999; 84:389-400; PMID:10665836; http://dx.doi.org/10.1016/S0163-7258(99)00043-1
  • Torano EG, Petrus S, Fernandez AF, Fraga MF. Global DNA hypomethylation in cancer: review of validated methods and clinical significance. Clin Chem Lab Med 2012; 50:1733-42; PMID:23089701; http://dx.doi.org/10.1515/cclm-2011-0902
  • Achwal CW, Chandra HS. A sensitive immunochemical method for detecting 5mC in DNA fragments. FEBS Lett 1982; 150:469-72; PMID:6819163; http://dx.doi.org/10.1016/0014-5793(82)80791-6
  • Oakeley EJ, Podesta A, Jost JP. Developmental changes in DNA methylation of the two tobacco pollen nuclei during maturation. Proc Nat Acad Sci U S A 1997; 94:11721-5; PMID:9326677; http://dx.doi.org/10.1073/pnas.94.21.11721
  • Reynaud C, Bruno C, Boullanger P, Grange J, Barbesti S, Niveleau A. Monitoring of urinary excretion of modified nucleosides in cancer patients using a set of six monoclonal antibodies. Cancer Lett 1992; 61:255-62; PMID:1739950; http://dx.doi.org/10.1016/0304-3835(92)90296-8
  • Kremer D, Metzger S, Kolb-Bachofen V. Quantitative measurement of genome-wide DNA methylation by a reliable and cost-efficient enzyme-linked immunosorbent assay technique. Anal Biochem 2012; 422:74-8; PMID:22197418; http://dx.doi.org/10.1016/j.ab.2011.11.033
  • Niveleau A, Drouet E, Reynaud C, Fares F, Bruno C, Pain C. Polymerase chain reaction products containing 5-methyldeoxycytidine: a microplate immunoquantitation method. Nucleic Acids Res 1994; 22:5508-9; PMID:7816646; http://dx.doi.org/10.1093/nar/22.24.5508
  • Li Y, Miyanari Y, Shirane K, Nitta H, Kubota T, Ohashi H, Okamoto A, Sasaki H. Sequence-specific microscopic visualization of DNA methylation status at satellite repeats in individual cell nuclei and chromosomes. Nucleic Acids Res 2013; 41:e186; PMID:23990328; http://dx.doi.org/10.1093/nar/gkt766
  • Pfarr W, Webersinke G, Paar C, Wechselberger C. Immunodetection of 5'-methylcytosine on Giemsa-stained chromosomes. Biotechniques 2005; 38:527-8, 30; PMID:15884667; http://dx.doi.org/10.2144/05384BM01
  • Gertych A, Farkas DL, Tajbakhsh J. Measuring topology of low-intensity DNA methylation sites for high-throughput assessment of epigenetic drug-induced effects in cancer cells. Exp Cell Res 2010; 316:3150-60; PMID:20813111; http://dx.doi.org/10.1016/j.yexcr.2010.08.013
  • Habib M, Fares F, Bourgeois CA, Bella C, Bernardino J, Hernandez-Blazquez F, de Capoa A, Niveleau A. DNA global hypomethylation in EBV-transformed interphase nuclei. Exp Cell Res 1999; 249:46-53; PMID:10328952; http://dx.doi.org/10.1006/excr.1999.4434
  • Karouzakis E, Gay RE, Michel BA, Gay S, Neidhart M. DNA hypomethylation in rheumatoid arthritis synovial fibroblasts. Arthritis and Rheum 2009; 60:3613-22; PMID:19950268; http://dx.doi.org/10.1002/art.25018
  • Bian Y, Alberio R, Allegrucci C, Campbell KH, Johnson AD. Epigenetic marks in somatic chromatin are remodelled to resemble pluripotent nuclei by amphibian oocyte extracts. Epigenetics 2009; 4:194-202; PMID:19440040; http://dx.doi.org/10.4161/epi.4.3.8787
  • Li C, Chen Z, Liu Z, Huang J, Zhang W, Zhou L, Keefe DL, Liu L. Correlation of expression and methylation of imprinted genes with pluripotency of parthenogenetic embryonic stem cells. Hum Mol Gen 2009; 18:2177-87; PMID:19324901; http://dx.doi.org/10.1093/hmg/ddp150
  • Santos F, Dean W. Using immunofluorescence to observe methylation changes in mammalian preimplantation embryos. Methods Mol Biol 2006; 325:129-37; PMID:16761724.
  • Santos F, Hendrich B, Reik W, Dean W. Dynamic reprogramming of DNA methylation in the early mouse embryo. Dev Biol 2002; 241:172-82; PMID:11784103; http://dx.doi.org/10.1006/dbio.2001.0501
  • MacKay AB, Mhanni AA, McGowan RA, Krone PH. Immunological detection of changes in genomic DNA methylation during early zebrafish development. Genome 2007; 50:778-85; PMID:17893737; http://dx.doi.org/10.1139/G07-055
  • Nair SS, Coolen MW, Stirzaker C, Song JZ, Statham AL, Strbenac D, Robinson MD, Clark SJ. Comparison of methyl-DNA immunoprecipitation (MeDIP) and methyl-CpG binding domain (MBD) protein capture for genome-wide DNA methylation analysis reveal CpG sequence coverage bias. Epigenetics 2011; 6:34-44; PMID:20818161; http://dx.doi.org/10.4161/epi.6.1.13313
  • Jones PA, Taylor SM. Cellular differentiation, cytidine analogs and DNA methylation. Cell 1980; 20:85-93; PMID:6156004; http://dx.doi.org/10.1016/0092-8674(80)90237-8
  • Leonhardt H, Page AW, Weier HU, Bestor TH. A targeting sequence directs DNA methyltransferase to sites of DNA replication in mammalian nuclei. Cell 1992; 71:865-73; PMID:1423634; http://dx.doi.org/10.1016/0092-8674(92)90561-P
  • Hervouet E, Nadaradjane A, Gueguen M, Vallette FM, Cartron PF. Kinetics of DNA methylation inheritance by the Dnmt1-including complexes during the cell cycle. Cell division 2012; 7:5; PMID:22348533; http://dx.doi.org/10.1186/1747-1028-7-5
  • Brown SE, Fraga MF, Weaver IC, Berdasco M, Szyf M. Variations in DNA methylation patterns during the cell cycle of HeLa cells. Epigenetics 2007; 2:54-65; PMID:17965591; http://dx.doi.org/10.4161/epi.2.1.3880
  • Yamagata Y, Szabo P, Szuts D, Bacquet C, Aranyi T, Paldi A. Rapid turnover of DNA methylation in human cells. Epigenetics 2012; 7:141-5; PMID:22395463; http://dx.doi.org/10.4161/epi.7.2.18906
  • Patel K, Dickson J, Din S, Macleod K, Jodrell D, Ramsahoye B. Targeting of 5-aza-2'-deoxycytidine residues by chromatin-associated DNMT1 induces proteasomal degradation of the free enzyme. Nucleic Acids Res 2010; 38:4313-24; PMID:20348135; http://dx.doi.org/10.1093/nar/gkq187
  • Claus R, Pfeifer D, Almstedt M, Zucknick M, Hackanson B, Plass C, Lubbert M. Decitabine induces very early in vivo DNA methylation changes in blasts from patients with acute myeloid leukemia. Leuk Res 2013; 37:190-6; PMID:23158571; http://dx.doi.org/10.1016/j.leukres.2012.10.015
  • Oki Y, Jelinek J, Shen L, Kantarjian HM, Issa JP. Induction of hypomethylation and molecular response after decitabine therapy in patients with chronic myelomonocytic leukemia. Blood 2008; 111:2382-4; PMID:18055864; http://dx.doi.org/10.1182/blood-2007-07-103960
  • Aparicio A, North B, Barske L, Wang X, Bollati V, Weisenberger D, Yoo C, Tannir N, Horne E, Groshen S, et al. LINE-1 methylation in plasma DNA as a biomarker of activity of DNA methylation inhibitors in patients with solid tumors. Epigenetics 2009; 4:176-84; PMID:19421002; http://dx.doi.org/10.4161/epi.4.3.8694
  • Tsai HC, Li H, Van Neste L, Cai Y, Robert C, Rassool FV, Shin JJ, Harbom KM, Beaty R, Pappou E, et al. Transient low doses of DNA-demethylating agents exert durable antitumor effects on hematological and epithelial tumor cells. Cancer cell 2012; 21:430-46; PMID:22439938; http://dx.doi.org/10.1016/j.ccr.2011.12.029
  • Wersto RP, Chrest FJ, Leary JF, Morris C, Stetler-Stevenson MA, Gabrielson E. Doublet discrimination in DNA cell-cycle analysis. Cytometry 2001; 46:296-306; PMID:11746105; http://dx.doi.org/10.1002/cyto.1171
  • Song L, James SR, Kazim L, Karpf AR. Specific method for the determination of genomic DNA methylation by liquid chromatography-electrospray ionization tandem mass spectrometry. Anal Chem 2005; 77:504-10; PMID:15649046; http://dx.doi.org/10.1021/ac0489420

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.